Eric Eldering

14PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 25, 2026
Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies.

|Jun 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

Simon Mobach, Nick D Bergkamp, Ziliang Ma

|Mar 03, 2025
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Chaja F Jacobs, Fleur S Peters, Elena Camerini

|Jan 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast

|Jul 23, 2024
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.

Jaco A C van Bruggen, Fleur S Peters, Morris Mes

|Aug 08, 2023
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia.

Chiara Montironi, Chaja F Jacobs, Gaspard Cretenet

Pageof 3

Frequent Collaborators

11 joint publications

Arnon P Kater

5 joint publications

Fleur S Peters

3 joint publications

Marco V Haselager

3 joint publications

Marcel Spaargaren